The Leprosy Mission Bangladesh Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2006
NCT00406861
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

The Leprosy Mission Bangladesh

Active Ingredients

Drugs in Other Trials (3)

methotrexate (1 trial)

montelukast (singulair) (1 trial)

prednisolone (hydeltra) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 3